menuMenu
  • WORLDWIDE
  • CONTACT US
  • About Us
    close
    • About Us
    • Corporate Responsibility
    • Our Work
      • – Antimicrobial Resistance
      • – Diabetes
      • – HIV
      • – Oncology
      • – Vaccine
    • Leadership
      • – Board of Directors
      • – Executive Committee
    • Access to Investigational Medicines
    • How We Operate
    • Our History
    • Our People
    • Featured Stories
  • Inventing For Life
  • Newsroom
  • Career
  • MSD Danmark 
  • About Us navigate_next
    • Corporate Responsibility
    • Our Worknavigate_next
      • Antimicrobial Resistance
      • Diabetes
      • HIV
      • Oncology
      • Vaccine
    • Leadershipnavigate_next
      • Board of Directors
      • Executive Committee
    • Access to Investigational Medicines
    • How We Operate
    • Our History
    • Our People
    • Featured Stories
  • Inventing For Life 
  • Newsroom
  • Career
  • Contact Us

Diabēts

Uzzināt vairāk

 
 

Onkoloģija

Uzzināt vairāk

 
 

Vakcīnas

Uzzināt vairāk

 
 

HIV

Uzzināt vairāk

 
 

MSD Latvija
Citas MSD lapas
 
 
    • SIA Merck Sharp & Dohme Latvija Skanstes iela 50a, Rīga LV-1013, Latvija Telefons: 67 364 224 E-pasts: msd_lv@merck.com​​
Cookie Preferences
 
 
  • OTHER MSD SITES
    MSD for Mothers
  • Corporate Responsibility
    MSD Corporate Responsibility website chevron_right
    Transparency Disclosures chevron_right
  • MSD Animal Health
  • MSD Manuals
  • Univadis (a service of MSD subsidiary Aptus Health)
 
 
 

Autortiesības© 2017 SIA "Merck Sharp & Dohme Latvija" - Merck & Co., Inc., Kenilworth, NJ, U.S.A., meitas uzņēmums.

  • Preču zīmes
  • Līgums par lietošanas nosacījumiem
  • Privātuma politika
  • Autortiesības
Image: Circle Close Icon

Forward-Looking Statement ×
 

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.